Commission Implementing Decision (EU) 2023/2484of 9 November 2023amending Implementing Decision 2012/715/EU as regards the inclusion of TaiwanThis Decision should not be interpreted as reflecting any official position of the European Union with regard to the legal status of Taiwan. in the list of third countries established by that Decision(Text with EEA relevance)

Commission Implementing Decision (EU) 2023/2484 of 9 November 2023 amending Implementing Decision 2012/715/EU as regards the inclusion of Taiwan This Decision should not be interpreted as reflecting any official position of the European Union with regard to the legal status of Taiwan. in the list of third countries established by that Decision (Text with EEA relevance) THE EUROPEAN COMMISSION, Having regard to the Treaty on the Functioning of the European Union, Having regard to Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community Code relating to medicinal products for human use OJ L 311, 28.11.2001, p. 67. , and in particular Article 111b(1) thereof, Whereas: (1) In accordance with Article 111b(1) of Directive 2001/83/EC, a third country may request the Commission to assess whether that country’s regulatory framework applicable to active substances exported to the Union, and the respective control and enforcement activities, ensure a level of protection of public health equivalent to that of the Union in order to be included in a list of third countries ensuring an equivalent level of protection of public health. (2) Taiwan requested, by letter dated 8 December 2021, to be listed in accordance with Article 111b(1) of Directive 2001/83/EC. (3) The Commission has assessed the request by carrying on a review of the relevant documentation and an on-site review of Taiwan’s regulatory system from 20 to 27 April 2023 including an observed inspection and taking due account of the responses, information and documentation provided during the audit by the Taiwanese competent authority, Taiwan Food and Drug Administration (TFDA) within the Ministry of Health and Welfare. (4) Based on that equivalence assessment, the Commission concluded that the requirements of Article 111b(1) of Directive 2001/83/EC were fulfilled. (5) Commission Implementing Decision 2012/715/EU Commission Implementing Decision 2012/715/EU of 22 November 2012 establishing a list of third countries with a regulatory framework applicable to active substances for medicinal products for human use and the respective control and enforcement activities ensuring a level of protection of public health equivalent to that in the Union, in accordance with Directive 2001/83/EC of the European Parliament and of the Council (OJ L 325, 23.11.2012, p. 15). should be amended accordingly. HAS ADOPTED THIS DECISION:

Article 1

The Annex to Implementing Decision 2012/715/EU is replaced by the text set out in the Annex to this Decision.

Article 2

This Decision shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union. Done at Brussels, 9 November 2023. For the Commission The President Ursula von der Leyen

Annex

ANNEX

Annex

ANNEX List of third countries with a regulatory framework applicable to active substances exported to the Union and the respective control and enforcement activities ensuring a level of protection of public health equivalent to that in the Union